Determining when or if companies must inform investors that their top executives have contracted coronavirus calls for a delicate balancing act between complying with regulatory requirements and respecting employees’ privacy rights, observers say. Experts recommend companies carefully weigh the particular circumstances of each case. Experts say that while the SEC lists the specific type of disclosures that must be made, there is also a catchall category into which reports on executives’ health would fall.
Bonnie Hochman Rothell was called for comment on this issue. Read the full article here. Business Insurance membership required.